Petrie-Flom Center 2024 Annual Conference: Law and Policy of Psychedelic Medicine Panel one: Psychedelics in medical and therapeutic practice This conference, which will seed a book, seeks to explore the law and policy challenges and opportunities resulting from increased clinical research, private investment, and political interest in psychedelic medicines. Panelists: Moderator: Rebecca Weintraub Brendel, Director, Harvard Medical School Center for Bioethics, Director, Master of Science in Bioethics Degree Program, and Associate Professor of Psychiatry, Harvard Medical School From efficacy to effectiveness: Evaluating psychedelic randomized controlled trials for trustworthy evidence-based policy Eduardo Schenberg, Presidente, Instituto Phaneros Set, setting & standard of care: Exploring medical malpractice in psychedelic-assisted therapy Logan Fahrenkopf, Incoming Associate, Wilson Sonsini Goodrich & Rosati Experiential training for psychedelic therapists? Legal and licensure-related challenges for psychedelic-assisted therapy training programs Franklin King, Psychiatrist and Director of Training and Education, Massachusetts General Hospital Center for Neuroscience of Psychedelics
